Please login to the form below
infectious diseases
This page shows the latest infectious diseases news and features for those working in and with pharma, biotech and healthcare.
Gilead poaches Genentech-exec Merdad Parsey for its new CMO
His clinical expertise and experience across a number of therapeutic areas, including inflammation, oncology and infectious diseases will be particularly useful as Gilead continues to stake its claim in these markets.
Latest news
-
'Therapeutic overcrowding' could hit big pharma returns
Rare diseases is also a major growth area as big pharma continues to back away from traditional therapeutic areas like cardiovascular, renal, metabolic and infectious diseases.
-
GSK to develop Ionis hepatitis B drugs
We believe GSK's development and commercialisation expertise in infectious diseases makes them the ideal partner to help address this high unmet need.". ... It is also expanding its partnerships, including ongoing development deals with Biogen in rare
-
BioNTech raises €290m for mRNA cancer vaccine platform
That followed a January deal to add a monoclonal antibody platform developed by fellow German biotech MAB Discovery, and a collaboration with the University of Pennsylvania on mRNA vaccines for infectious ... diseases. There has been a busy few months on
-
Non-antibiotic could ‘transform pneumonia therapy’
The results are published in The Lancet Infectious Diseases, and an editorial accompanying the study suggests this should be seen as a “medical breakthrough”. ... tackle infectious diseases are developed.
-
Biotech now vital to pipelines – but success rates falling
Among these drugs, 27% were treatments for cancer and its symptoms and 20% are for the treatment of infectious diseases.
More from news
Approximately 4 fully matching, plus 174 partially matching documents found.
Latest Intelligence
-
Biotech profile: Tom Evans, CEO, Vaccitech.
He moved to the University of Rochester as Associate Professor for 5 years, before becoming Infectious Diseases Division Chief and tenured full Professor at the University of California, Davis. ... In 2005, he joined the Novartis Institutes for
-
The threat of antimicrobial resistance
A study recently reported in The Lancet Infectious Diseases found that antibiotics are now failing to work in a fifth of patients who suffer an infection after hospital surgery.
-
Deal Watch February 2016
Alere has annual sales of approximately $2.5bn from a portfolio of point-of-care products in areas including cardiometabolic, infectious diseases such as HIV, malaria, syphilis, E. ... Pronutria's focus is on the development of therapeutics and
-
Searching for health
year. The pharma work is organised into therapeutic areas covering cancers, infectious diseases, immunology, cardiovascular and metabolism diseases with each having dedicated research teams managing all aspects - from finding new compounds
-
The world is our laboratory
Our goal is to improve patient outcomes in the most serious unmet medical needs of our time, including neglected diseases. ... Focused specialties. At Janssen, we have focused our research into five important therapeutic areas: Cardiovascular &Metabolic
More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.
Latest appointments
-
New hires at Bayer, Eisai and Accord Healthcare
Most recently, she held the position of vice president of M&A operations and divestitures and led the infectious diseases and vaccines business development. ... She joins Eisai from Merck, where she served as executive director, clinical quality assurance
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
and infectious diseases.
-
Nabriva Therapeutics appoints chief medical officer
Commenting on the appointment, Dr Colin Broom, chief executive officer of Nabriva, said: “Jennifer has broad expertise in infectious diseases and internal medicine with extensive experience in both clinical development and
-
Dr Jan van de Winkel joins Austrian biotech Hookipa
As Hookipa grows and progresses to become an integrated biotech company with multiple clinical programmes in infectious diseases and immune-oncology, Jan’s experience of building companies and his scientific insight
-
Emotive expands client services team
Biology graduate Rob Mackichan joins the agency as an account manager, bringing experience of working with infectious diseases, rare diseases and medical devices.
More from appointments
Approximately 0 fully matching, plus 36 partially matching documents found.
Latest from PMHub
-
emotive adds to medical team with new Scientific Lead and Associate Medical Writer
Following a busy year and with a number of new Global and EMEA account wins including two pre-launch products for rare diseases, emotive has strengthened the medical team with the ... in rare diseases such as Gaucher disease and Cushing’s disease
-
Australian Flu and the dilemma of naming diseases
In recent times, the potentially damaging consequences of ‘naming’ infectious diseases have been identified, and in 2015 the World Health Organisation (WHO) introduced its ‘Best Practices for the Naming of New ... Human Infectious Diseases’,
-
IGNIFI
cardiovascular disease. diabetes. women’s health. nutrition. allergy. infectious diseases. wound care.
-
New insights into making behavioural change work
The focus of pharmacological interventions has experienced a shift over recent years, with a greater emphasis placed on addressing lifestyle conditions than on fighting infectious diseases. ... Lifestyle conditions, or noncommunicable diseases (NCDs),
-
To track disease, follow the money
Contrast this with the slow march of infectious diseases before the era of mass movement and jet travel. ... But banknotes do not spread or reproduce like infectious agents, more's the pity, nor does the movement of money accurately reproduce the
More from PMHub
Approximately 1 fully matching, plus 10 partially matching documents found.
Featured jobs
-
Senior Copywriter
-
Salary TBC
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
-
Account Director, Medical Education
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
-
Senior Medical Writer
-
Salary TBC
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
Subscribe to our email news alerts
- Leading AstraZeneca’s return to growth in Europe
- Novartis bags US okay for Lucentis follow-up Beovu in wet AMD
- GSK forms cell therapy R&D pact with star-studded biotech
- Bayer/J&J claim new FDA okay for clot drug Xarelto
- Allergan investors back AbbVie deal, but is a tax charge looming?
- Bayer opens AI-enabled drug discovery center in UK
- Spotlight interview: 15 minutes on PR in pharma
- Changing healthcare, one film at a time
- Faisal Ahmed joins healthcare comms agency Sudler London
- Red Consultancy appoints MD in its health division
- Takeda offloads select portfolio to Acino ahead of Shire takeover
- Wilmington Healthcare appoints new consultants
PMHub
Ashfield
Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...
Latest intelligence
- eyeforpharma Marketing and Customer Innovation Europe
- By Richard Springham...
- The Golden Goose
- Why it’s so hard for the US to curb runaway drug prices...
- What is changing in cardiovascular disease care?
- Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...
Quick links
Infographics
